Cargando…

Urine Phenylacetylglutamine Determination in Patients with Hyperphenylalaninemia

Phenylketonuria (PKU), an autosomal-recessive inborn error of phenylalanine (Phe) metabolism is the most prevalent disorder of amino acid metabolism. Currently, clinical follow-up relies on frequent monitoring of Phe levels in blood. We hypothesize that the urine level of phenylacetylglutamine (PAG)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andrade, Fernando, Cano, Ainara, Unceta Suarez, María, Arza, Arantza, Vinuesa, Ana, Ceberio, Leticia, López-Oslé, Nuria, de Frutos, Gorka, López-Oceja, Raquel, Aznal, Elena, González-Lamuño, Domingo, de las Heras, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396897/ https://www.ncbi.nlm.nih.gov/pubmed/34441968 http://dx.doi.org/10.3390/jcm10163674

Ejemplares similares

Micronutrient in hyperphenylalaninemia
por: Crujeiras, Vanesa, et al.
Publicado: (2015)

Phenylacetylglutamine, a Novel Biomarker in Acute Ischemic Stroke
por: Yu, Fang, et al.
Publicado: (2021)

Cognitive functioning in mild hyperphenylalaninemia
por: de la Parra, Alicia, et al.
Publicado: (2015)

Importance of Timely Treatment Initiation in Infantile-Onset Pompe Disease, a Single-Centre Experience
por: de las Heras, Javier, et al.
Publicado: (2021)

Phenylacetylglutamine as a risk factor and prognostic indicator of heart failure
por: Zong, Xiao, et al.
Publicado: (2022)

Mild hyperphenylalaninemia: to treat or not to treat
por: van Spronsen, Francjan J.
Publicado: (2011)

The Utility of Genomic Testing for Hyperphenylalaninemia
por: Tendi, Elisabetta Anna, et al.
Publicado: (2022)

BH(4)-deficient hyperphenylalaninemia in Russia
por: Gundorova, Polina, et al.
Publicado: (2021)

Psychopathological Risk Assessment in Children with Hyperphenylalaninemia
por: Risoleo, Maria Cristina, et al.
Publicado: (2022)

Clinical, genetic, and experimental research of hyperphenylalaninemia
por: Chen, Anqi, et al.
Publicado: (2023)

Exposures of Phenylacetic Acid and Phenylacetylglutamine Across Different Subpopulations and Correlation with Adverse Events
por: Wang, Xiaofeng, et al.
Publicado: (2021)

Alteration of the gut microbiota and metabolite phenylacetylglutamine in patients with severe chronic heart failure
por: Zhang, Zhendong, et al.
Publicado: (2023)

Food Habits and Lifestyle in Hyperphenylalaninemia Patients: Should These Be Monitored?
por: Dicintio, Annamaria, et al.
Publicado: (2022)

Executive functions in preschool children with moderate hyperphenylalaninemia and phenylketonuria: a prospective study
por: Paermentier, Laetitia, et al.
Publicado: (2023)

Gut-Derived Metabolite Phenylacetylglutamine and White Matter Hyperintensities in Patients With Acute Ischemic Stroke
por: Yu, Fang, et al.
Publicado: (2021)

Dysbiosis of Gut Microbiota and Metabolite Phenylacetylglutamine in Coronary Artery Disease Patients With Stent Stenosis
por: Fang, Chen, et al.
Publicado: (2022)

Phenylacetylglutamine as a novel biomarker of type 2 diabetes with distal symmetric polyneuropathy by metabolomics
por: Xu, J., et al.
Publicado: (2022)

Prevalence of Neonatal Hyperphenylalaninemia in Yazd Province, Iran
por: Ordooei, Mahtab, et al.
Publicado: (2015)

Prognostic value of plasma phenylalanine and gut microbiota-derived metabolite phenylacetylglutamine in coronary in-stent restenosis
por: Fu, Yuan, et al.
Publicado: (2022)

Incidence of Neonatal Hyperphenylalaninemia in Fars Province, South Iran
por: Karamifar, Hamdollah, et al.
Publicado: (2010)

Behavioral and Neurochemical Characterization of New Mouse Model of Hyperphenylalaninemia
por: Pascucci, Tiziana, et al.
Publicado: (2013)

Anthropometry and bone mineral density in treated and untreated hyperphenylalaninemia
por: Zerjav Tansek, Mojca, et al.
Publicado: (2020)

Body Composition Profile of Young Patients With Phenylketonuria and Mild Hyperphenylalaninemia
por: Doulgeraki, Artemis, et al.
Publicado: (2014)

Examining the blood amino acid status in pretherapeutic patients with hyperphenylalaninemia
por: Liang, Lili, et al.
Publicado: (2019)

Neonatal screening and genotype-phenotype correlation of hyperphenylalaninemia in the Chinese population
por: Wang, Xin, et al.
Publicado: (2021)

Tetrahydrobiopterin responsiveness in a series of 53 cases of phenylketonuria and hyperphenylalaninemia in Iran
por: Setoodeh, Aria, et al.
Publicado: (2015)

Creatine Levels in Patients with Phenylketonuria and Mild Hyperphenylalaninemia: A Pilot Study
por: Verduci, Elvira, et al.
Publicado: (2021)

Supportive care in a patient with Alstrom syndrome with hyperphenylalaninemia and sleep problems
por: Jalilolghadr, Shabnam, et al.
Publicado: (2023)

Mild hyperphenylalaninemia (hpa) presenting as orthostatic tremor: a case report
por: Li, Hua, et al.
Publicado: (2022)

Hyperphenylalaninemias genotyping: Results of over 60 years of history in Lombardy, Italy
por: Rovelli, Valentina, et al.
Publicado: (2022)

DNAJC12 deficiency: Mild hyperphenylalaninemia and neurological impairment in two siblings
por: Fino, Edoardo, et al.
Publicado: (2023)

Urinary phenylacetylglutamine (U-PAGN) concentration as biomarker for adherence in patients with urea cycle disorders (UCD) treated with glycerol phenylbutyrate
por: Mokhtarani, M., et al.
Publicado: (2015)

Diagnostic and therapeutic recommendations for the treatment of hyperphenylalaninemia in patients 0–4 years of age
por: Muntau, Ania C., et al.
Publicado: (2018)

Telehealth and COVID-19: Empowering Standards of Management for Patients Affected by Phenylketonuria and Hyperphenylalaninemia
por: Rovelli, Valentina, et al.
Publicado: (2021)

Haplotype-based Noninvasive Prenatal Diagnosis of Hyperphenylalaninemia through Targeted Sequencing of Maternal Plasma
por: Ye, Jun, et al.
Publicado: (2018)

Clinical and Genetic Characteristics of Patients with Mild Hyperphenylalaninemia Identified by Newborn Screening Program in Japan
por: Odagiri, Shino, et al.
Publicado: (2021)

Data on phenylalanine-to-tyrosine ratios in assessment of tetrahydrobiopterin (BH(4))-responsiveness in patients with hyperphenylalaninemia
por: Lampret, Barbka Repic, et al.
Publicado: (2022)

Stress Hyperphenylalaninemia Is Associated With Mortality in Cardiac ICU: Clinical Factors, Genetic Variants, and Pteridines*
por: Wang, Chao-Hung, et al.
Publicado: (2022)

Detection of Single-Nucleotide and Copy Number Defects Underlying Hyperphenylalaninemia by Next-Generation Sequencing
por: Tendi, Elisabetta Anna, et al.
Publicado: (2023)

A Case of Suspected Hyperphenylalaninemia at Newborn Screening by Tandem Mass Spectrometry during Total Parenteral Nutrition
por: Pieragostino, Damiana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ecd748igo0398p6cm7g6cblopg